PrimeCell Therapeutics Inc. is a biotech company focused on the development of cell-based medicinal products with the aim to enhance the quality of human life. For the development and production process we utilize natural healing and regenerative properties of cells. Through highly specialised manipulation, we are able to influence cell properties to achieve the desired regenerative effect in affected human tissues.
PrimeCell Therapeutics provides patients with new highly personalised and effective treatment methods, which are based on human cells and tissues, especially in cases where pharmaceutical and other conventional treatment methods fail or when cell-based treatment is more convenient for a patient. PrimeCell Therapeutics is to primarily deal with preparation of autologous and allogeneic medicinal products for orthopaedic indications, ischemic diseases, in addition to skin defects and wound healing.
PrimeCell Therapeutics utilises natural healing and regenerative properties of cells and its components. Through specialised proven processes, we are able to influence cell properties to achieve the desired regenerative effect in the affected human tissues.
One of the cornerstones of PrimeCell Therapeutics activities is an intensive co-operation with renowned domestic and international scientific institutions and clinical centres with the goal of transferring the fundamental research results into clinical practise for patients use. Furthermore, PrimeCell Therapeutics is to expand its current network of more than one hundred clinical centres and partners in the Czech Republic and abroad.
PrimeCell Therapeutics was founded in 2007. It is recognised as one of the top European investors in regenerative medicine. It owns and operates a highly innovative development and production infrastructure for applied research and for the procession and production of human cells and tissues. PrimeCell Therapeutics portfolio boasts of 8000 m2 laboratory space of which 2000 m2 are cGMP laboratories dedicated to the development and manufacture of cell and tissue products.